RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to GHR

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	2.0	Recruiting	ClinicalTrials
PEGVISOMANT	Protein	acromegaly	Growth hormone receptor antagonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Turner syndrome	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	COVID-19	Growth hormone receptor agonist	4.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	short bowel syndrome	Growth hormone receptor agonist	4.0	-	DailyMed
PEGVISOMANT	Protein	acromegaly	Growth hormone receptor antagonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	hypochondroplasia	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	burn	Growth hormone receptor agonist	2.0	Active, not recruiting	ClinicalTrials
SOMATROPIN	Protein	Turner syndrome	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Noonan syndrome	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Facioscapulohumeral dystrophy	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	hypopituitarism	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
LONAPEGSOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	3.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	Prader-Willi syndrome	Growth hormone receptor agonist	3.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	infertility	Growth hormone receptor agonist	2.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	Crohn's disease	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROGON	Protein	pituitary dwarfism	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Tendinopathy	Growth hormone receptor agonist	2.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	genetic endocrine growth disease	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Turner syndrome	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	infertility	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	osteogenesis imperfecta	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	mucopolysaccharidosis type 2	Growth hormone receptor agonist	2.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	3.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Albright hereditary osteodystrophy	Growth hormone receptor agonist	2.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	4.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	obesity	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Cachexia	Growth hormone receptor agonist	4.0	-	DailyMed
PEGVISOMANT	Protein	polyostotic fibrous dysplasia	Growth hormone receptor antagonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	lipodystrophy	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMAPACITAN	Small molecule	pituitary dwarfism	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	obesity	Growth hormone receptor antagonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	female infertility	Growth hormone receptor agonist	0.5	Unknown status	ClinicalTrials
SOMATROPIN	Protein	gonadal dysgenesis	Growth hormone receptor agonist	4.0	-	DailyMed
PEGVISOMANT	Protein	partial lipodystrophy	Growth hormone receptor antagonist	2.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	sarcopenia	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	0.5	Completed	ClinicalTrials
SOMATROPIN	Protein	Short stature	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	primary short bowel syndrome	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	obesity	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	genetic endocrine growth disease	Growth hormone receptor agonist	1.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	cystic fibrosis	Growth hormone receptor agonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	metabolic syndrome	Growth hormone receptor agonist	4.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Growth delay	Growth hormone receptor agonist	4.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Spinal cord injury	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	prostate adenocarcinoma	Growth hormone receptor antagonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	Short stature	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	sarcoma	Growth hormone receptor antagonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	4.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	2.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	Cognitive impairment	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	achondroplasia	Growth hormone receptor agonist	4.0	Not yet recruiting	ClinicalTrials
SOMATROPIN	Protein	pregnancy	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	hypopituitarism	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	genetic endocrine growth disease	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	cardiovascular disease	Growth hormone receptor agonist	3.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Short stature	Growth hormone receptor agonist	1.0	Active, not recruiting	ClinicalTrials
SOMATROPIN	Protein	burn	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	mucopolysaccharidosis type 6	Growth hormone receptor agonist	2.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	short bowel syndrome	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	ligament rupture	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	lung neoplasm	Growth hormone receptor antagonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	pituitary gland disease	Growth hormone receptor agonist	4.0	-	DailyMed
PEGVISOMANT	Protein	pituitary gland disease	Growth hormone receptor antagonist	3.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	pituitary gland disease	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	acromegaly	Growth hormone receptor antagonist	4.0	-	DailyMed
SOMATROPIN	Protein	infertility	Growth hormone receptor agonist	2.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	3.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	attention deficit hyperactivity disorder	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Prader-Willi syndrome	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	brain injury	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	endocrine system disease	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	2.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Growth delay	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	amyotrophic lateral sclerosis	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Short stature	Growth hormone receptor agonist	4.0	Active, not recruiting	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	cirrhosis of liver	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	cystic fibrosis	Growth hormone receptor agonist	2.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	heart failure	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	burn	Growth hormone receptor agonist	2.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	osteoarthritis, knee	Growth hormone receptor agonist	0.5	Unknown status	ClinicalTrials
SOMATROGON	Protein	pituitary dwarfism	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Prader-Willi syndrome	Growth hormone receptor agonist	3.0	Active, not recruiting	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	2.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Prader-Willi syndrome	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	female infertility	Growth hormone receptor agonist	1.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Turner syndrome	Growth hormone receptor agonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	Small for gestational age	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	brain injury	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	cardiovascular disease	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Short stature	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	diabetes mellitus	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	spinal muscular atrophy	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	cystic fibrosis	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Monosomy 22q13	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	3.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	infertility	Growth hormone receptor agonist	1.0	Completed	ClinicalTrials
SOMATROPIN	Protein	non-alcoholic fatty liver disease	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Growth abnormality	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Growth abnormality	Growth hormone receptor agonist	2.0	Enrolling by invitation	ClinicalTrials
SOMATROPIN	Protein	cystic fibrosis	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	tibia fracture	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	HIV wasting syndrome	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	acromegaly	Growth hormone receptor antagonist	4.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	infertility	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	breast neoplasm	Growth hormone receptor antagonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Phelan-McDermid syndrome	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Turner syndrome	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	short bowel syndrome	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	Crohn's disease	Growth hormone receptor agonist	2.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	hypothyroidism	Growth hormone receptor agonist	4.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	pseudohypoparathyroidism type 1A	Growth hormone receptor agonist	2.0	Recruiting	ClinicalTrials
SOMATROPIN	Protein	HIV-1 infection	Growth hormone receptor agonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	HIV infection	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	heart failure	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	short bowel syndrome	Growth hormone receptor agonist	4.0	Terminated	ClinicalTrials
LONAPEGSOMATROPIN	Protein	pituitary dwarfism	Growth hormone receptor agonist	4.0	-	FDA
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	4.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	Prader-Willi syndrome	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	endocrine system disease	Growth hormone receptor agonist	3.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	3.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	cirrhosis of liver	Growth hormone receptor agonist	2.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	fibromyalgia	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
SOMATROPIN	Protein	brain injury	Growth hormone receptor agonist	0.5	Unknown status	ClinicalTrials
SOMATROPIN	Protein	brain injury	Growth hormone receptor agonist	4.0	Withdrawn	ClinicalTrials
SOMATROPIN	Protein	fetal growth restriction	Growth hormone receptor agonist	2.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	Growth delay	Growth hormone receptor agonist	4.0	-	DailyMed
SOMATROPIN	Protein	aging	Growth hormone receptor agonist	2.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	Growth delay	Growth hormone receptor agonist	1.0	Unknown status	ClinicalTrials
SOMATROPIN	Protein	endocrine system disease	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	female infertility	Growth hormone receptor agonist	4.0	Completed	ClinicalTrials
PEGVISOMANT	Protein	colorectal neoplasm	Growth hormone receptor antagonist	1.0	Terminated	ClinicalTrials
SOMATROPIN	Protein	heart failure	Growth hormone receptor agonist	2.0	Suspended	ClinicalTrials
SOMATROPIN	Protein	systemic juvenile idiopathic arthritis	Growth hormone receptor agonist	3.0	Completed	ClinicalTrials
SOMATROPIN	Protein	hypopituitarism	Growth hormone receptor agonist	2.0	Completed	ClinicalTrials
SOMATROPIN	Protein	chronic kidney disease	Growth hormone receptor agonist	3.0	Terminated	ClinicalTrials

Welcome to

RBP World!

Drugs target to GHR

Targets details